Skip to content

    Recently Viewed


      No more epidemics

      Dr. Johan Van Hoof, Global Head of Janssen Vaccines, sat down for an on-camera interview with The Business Debate that has been posted on The Wall Street Journal. He spoke about Johnson & Johnson’s commitment to combat Ebola through Janssen’s vaccine development program, global partnerships and broader activities to promote pandemic preparedness.

      Share Article
      share to
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.